Rufloxacin hydrochloride

CAS No. 106017-08-7

Rufloxacin hydrochloride( MF-934 hydrochloride )

Catalog No. M29613 CAS No. 106017-08-7

Rufloxacin hydrochloride is a fluoroquinolone antibacterial and inhibits topoisomerase. Rufloxacin hydrochloride inhibits B-cell differentiation in human mononuclear cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 43 Get Quote
100MG 71 Get Quote
200MG 105 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rufloxacin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Rufloxacin hydrochloride is a fluoroquinolone antibacterial and inhibits topoisomerase. Rufloxacin hydrochloride inhibits B-cell differentiation in human mononuclear cells.
  • Description
    Rufloxacin hydrochloride is a fluoroquinolone antibacterial and inhibits topoisomerase. Rufloxacin hydrochloride inhibits B-cell differentiation in human mononuclear cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MF-934 hydrochloride
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    106017-08-7
  • Formula Weight
    399.87
  • Molecular Formula
    C17H19ClFN3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 2 mg/mL (5.00 mM)
  • SMILES
    Cl.CN1CCN(CC1)c1c(F)cc2c3c1SCCn3cc(C(O)=O)c2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chitosan

    Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine.

  • 1,3-DIMETHYL-2-OXO-2...

    1,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOLE-5-CARBALDEHYDE

  • QcrB inhibitor TB47

    QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.